Keyword: autoimmune diseases


Lilly Boosts Immunology with Dice Buy

22.06.2023 -

Major drugmaker Eli Lilly is to pay up to $2.4 billion to acquire Dice Therapeutics, a US biotech specializing in developing oral medicines to treat chronic autoimmune...


Sun Pharma Boosts Dermatology Offering with Concert Buy

24.01.2023 -

Indian drugmaker Sun Pharmaceutical Industries is to buy US biotech Concert Pharmaceuticals, gaining access to the latter’s lead product candidate deuruxolitinib for...


Resilience and Mubadala in Biopharma Venture

17.01.2023 -

US biopharma manufacturing and technology company National Resilience has entered into an agreement with Abu Dhabi investor Mubadala Investment Company to build a...


Takeda Takes Nimbus Lakshmi for $4 Billion

16.12.2022 -

Japanese pharma Takeda is acquiring Nimbus Lakshmi, a wholly-owned subsidiary of US clinical-stage drug discovery company Nimbus Therapeutics, and its tyrosine kinase 2...


Bristol-Myers Squibb to Buy Padlock

24.03.2016 - US drugmaker Bristol-Myers Squibb (BMS) has signed an agreement to acquire Padlock Therapeutics, a privately owned biotechnology firm based at Cambridge, Massachusetts, which...


Celgene Offers $7.2 Billion for Receptos

17.07.2015 - US biotech firm Celgene has agreed to pay $7.2 billion, or $232 per share, to acquire compatriot Receptos, a biotech company that makes a potential blockbuster drug to treat...


Sanofi and Lead Pharma Seal Autoimmune R&D Pact

24.02.2015 - French drugmaker Sanofi and Dutch biotech Lead Pharma have entered a research collaboration and license agreement to discover, develop and commercialize small-molecule therapies...


Novozymes Biopharma Announces Research Agreement with EpiVax

12.02.2013 - Novozymes Biopharma today announced a collaborative research agreement with Rhode Island-based biotech company EpiVax, to help further the development of a treatment for autoimmune...